What does USP Chapter 797 relate to?

USP Chapter 797 specifically pertains to the requirements for compounding sterile preparations. This chapter provides guidelines aimed at ensuring the safety and quality of compounded sterile products by outlining the necessary practices, standards, and environments in which compounding must occur.

The primary goal is to minimize the risks associated with contamination of these sterile preparations, which can lead to serious health issues for patients. Chapter 797 addresses elements such as facilities, personnel training, equipment, and standard operating procedures, all of which are crucial for maintaining the integrity of sterile products throughout the compounding process. By focusing on these elements, USP Chapter 797 plays a critical role in protecting patient safety and ensuring that compounded medications meet high standards of quality and sterility.